Exasol AG (FRA:EXL)
2.960
-0.060 (-1.99%)
Last updated: Jul 31, 2025
Blueprint Medicines Market Cap
Exasol AG has a market cap or net worth of €76.83 million as of August 1, 2025. Its market cap has increased by 36.97% in one year.
Market Cap
76.83M
Enterprise Value
61.88M
Revenue
39.63M
Ranking
n/a
PE Ratio
335.00
Stock Price
$2.96
Market Cap Chart
Since May 25, 2020, Exasol AG's market cap has decreased from 271.82M to 76.83M, a decrease of -71.74%. That is a compound annual growth rate of -21.61%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 76.83M | 24.03% |
Dec 30, 2024 | 61.94M | -25.91% |
Dec 29, 2023 | 83.61M | 17.40% |
Dec 30, 2022 | 71.21M | -60.96% |
Dec 30, 2021 | 182.39M | -72.18% |
Dec 30, 2020 | 655.72M | 141.23% |
May 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 289.34B |
Siemens Aktiengesellschaft | 176.59B |
Deutsche Telekom AG | 154.36B |
Allianz SE | 131.75B |
Rheinmetall AG | 79.50B |
Siemens Energy AG | 77.36B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.55B |
Deutsche Bank Aktiengesellschaft | 54.97B |